Expression of proliferationand apoptosis-related genes in hpv-infected pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Cervical intraepithelial neoplasia (CIN) occurs in 1.3 to 2.7 cases per 1000 pregnancies, and the incidence of cervical cancer (CC) is 0.1-12 per 10,000 pregnancies. Changes in the expression of genes of various signaling pathways can serve as a prognostic factor for the transition of CIN to cancer. However, these processes are insufficiently studied, especially in pregnant women, which served as the basis for this study. Objective. Determination of the expression of proliferation- and apoptosis-related genes in pregnant women infected with human papillomaviruses (HPV) and their role in predicting the progression of cervical neoplasia. Methods. An open-label observational non-interventional cohort clinical study was conducted. 82 pregnant women infected with HPV were examined. Control group consisted of 25 pregnant women without HPV. All participants underwent general clinical examination, Kvant-21 test to determine the types of HPV, cytological examination of cervical smears, determination of the mRNA expression of the VEGFA, TGFb, BCL-2, BAG1, BAX genes in the epithelial cells of the cervical canal by the real-time polymerase chain reaction. Results. The expression of proliferation-related genes - VEGFA (in the presence of HPV-16, -39, and -58), TGF-b (HPV-16, -33, -39 and -59), BCL-2 (HPV-16, -52 and -58), BAG-1 (HPV-16, -31, -35, -58, and-87) was significantly higher compared to control. With LSIL (low grade squamous intraepithelial lesion), the expression of the VEGFA gene increased, and with HSIL (high grade squamous intraepithelial lesion), expression of all genes (except BAX) increased. So, the ability of some HPV types to change the expression of proliferation-related genes was revealed, but no changes in the expression of the BAX gene, which controls apoptosis, were observed. Conclusion. The most pronounced ability to change the expression of proliferation-related genes is possessed by HPV-16 and -58. In LSIL, an increase in the expression of only the VEGFA gene was revealed, in HSIL - increase in expression of all genes characterizing the proliferative potential. No changes in the expression of the BAX gene, which stimulates apoptosis, were found in HPV-infected pregnant women. The results of the study indicate the possibility of using these markers in predicting the progression of cervical lesions, but further research is required.

Full Text

Restricted Access

About the authors

Tamara N. Bebneva

Peoples' Friendship University of Russia

Email: bebn@mail.ru
Cand. Sci. (Med.) 6, Miklukho-Maklay str., Moscow 117198, Russian Federation

G. B Dikke

Academy of Medical Education n.a. F.I. Inozemtsev

Moscow, Russia

I. S Galkina

OOO DNA-Technology

Moscow, Russia

References

  1. Salcedo M.M., Damin A.P, Agnes G., et al. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil. Arch Gynecol Obstet. 2015;292(6):1273- 78. doi: 10.1007/s00404-015-3752-8.
  2. Niyibizi J., Zanre N., Mayrand M.-H., Trottier H. The association between adverse pregnancy outcomes and maternal human papillomavirus infection: A systematic review protocol. Syst Rev. 2017;6(1):56. doi: 10.1186/s13643-017-0443-5.
  3. Al-Halal H., Kezouh A., Abenhaim H. (2012). Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: A population-based study on 8.8 million births. Arch Gynecol Obstet. 2013;287(2):245-50. doi: 10.1007/s00404-012-2475-3.
  4. Beharee N., Shi Z., Wu D., Wang J. Diagnosis and treatment of cervical cancer in pregnant women. Cancer Med. 2019;8(12):5425-30. doi: 10.1002/cam4.2435.
  5. Rahmani A.H., Babiker A.Y, Alsahli M.A., et al. Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma. Open Access. Maced. J Med Sci. 2018;6(2):263-68. doi: 10.3889/oamjms.2018.089.
  6. Zhang J., Liu J., Zhu C., et al. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis. Oncotarget. 2017;8(15):24797-803. Doi: 10.18632/ oncotarget.15044.
  7. lancu I.V, Botezatu A., Goia-Rusanu C.D., et al. TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roum Arch Microbiol Immunol. 2010;69(3):113-18.
  8. Ciavattini A., Lucarini G., Castaldini C., et al. bcl-2 protein expression in cervical intraepitheFial neoplasia: no evidence of a prognostic significance in mild and moderate lesions. Anticancer Res. 1999;19(6B):5463-67.
  9. Shukla S., Dass J., Pujani M. p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18. South. Asian J Cancer. 2014;3(1):48-53. doi: 10.4103/22 78-330X.126524.
  10. Tang S.C. BAG-1, an anti-apoptotic tumour marker. IUBMB. Life. 2002;53(2):99-105. doi: 10.1080/15216540211473.
  11. Hassumi-Fukasawa M.K., Miranda-Camargo F.A., Zanetti B.R., et al. Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV). Pathol Oncol Res. 2012;18(4):929-37. doi: 10.1007/s12253-012-9523-y.
  12. Gene I.D. BAX BCL2 associated X, apoptosis regulator [Homo sapiens]. Gene ID: 581, updated on 22-Aug-2020. URL: https://www.ncbi.nlm. nih.gov/gene/581.
  13. Frenzel A., Grespi F, Chmelewskij W., Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 2009;14(4):584-96. doi: 10.1007/s10495-008-0300-z.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies